Forecast: Import of Alkaloids in Dosage Forms to Canada

The import of alkaloids in dosage forms to Canada is forecasted to decline from 2024 to 2028. In 2023, the value stood at approximately 56.5 million US dollars. The year-on-year decrease from 2024 to 2028 indicates a diminishing reliance on imported alkaloid dosage forms, where the value is expected to shrink from 52.668 million in 2024 to 35.412 million US dollars in 2028, representing a substantial drop. The average annual change, or CAGR, suggests a negative growth trajectory throughout this period.

Future trends to watch for:

• Shift towards local production and sourcing due to increased regulatory pressures and cost-saving initiatives.
• Impact of technological advancements in pharmaceuticals reducing dependency on imports.
• Potential policy changes affecting trade dynamics between Canada and major pharmaceutical-exporting countries.